Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue Guidance

Go back to Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue Guidance
IRONWOOD PHARMA-A (NASDAQ: IRWD) Delayed: 4.36 +0.13 (3.07%)
Previous Close $4.23    52 Week High $16.89 
Open $4.20    52 Week Low $7.35 
Day High $4.39    P/E N/A 
Day Low $4.17    EPS $-2.35 
Volume 7,690,202